GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (XCNQ:ASEP) » Definitions » Debt-to-Revenue

ASEP Medical Holdings (XCNQ:ASEP) Debt-to-Revenue : 0.24 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is ASEP Medical Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

ASEP Medical Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.02 Mil. ASEP Medical Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. ASEP Medical Holdings's annualized Revenue for the quarter that ended in Dec. 2023 was C$0.08 Mil. ASEP Medical Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.24.


ASEP Medical Holdings Debt-to-Revenue Historical Data

The historical data trend for ASEP Medical Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings Debt-to-Revenue Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-Revenue
N/A N/A 0.95

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A 0.24

Competitive Comparison of ASEP Medical Holdings's Debt-to-Revenue

For the Biotechnology subindustry, ASEP Medical Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASEP Medical Holdings's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's Debt-to-Revenue falls into.



ASEP Medical Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

ASEP Medical Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.02 + 0) / 0.021
=0.95

ASEP Medical Holdings's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.02 + 0) / 0.084
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


ASEP Medical Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ASEP Medical Holdings (XCNQ:ASEP) Business Description

Traded in Other Exchanges
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.
Executives
Murphy Enterprises Inc. Director

ASEP Medical Holdings (XCNQ:ASEP) Headlines

No Headlines